1Department of Preventive Medicine, Dankook University College of Medicine, Cheonan, Korea
2Republic of Korea Army Headquarters, Gyeryong, Korea
Copyright © 2017 The Korean Society for Preventive Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
The authors have no conflicts of interest associated with the material presented in this paper.
n (%) | Hg (μg/L) | p-value1 | AST (IU/L) | p-value1 | ALT (IU/L) | p-value1 | GGT (IU/L) | p-value1 | |
---|---|---|---|---|---|---|---|---|---|
Total | 508 (100.0) | 4.33 (1.94) | 21.2 (1.4) | 18.3 (1.7) | 23.4 (2.0) | ||||
Gender | |||||||||
Men | 211 (41.5) | 5.71 (1.94) | 23.2 (1.4) | 22.6 (1.6) | 36.1 (2.0) | ||||
Women | 297 (58.5) | 3.55 (1.80) | <0.001 | 19.8 (1.4) | <0.001 | 15.7 (1.6) | <0.001 | 17.2 (1.7) | <0.001 |
Age at baseline (y) | |||||||||
≤29 | 53 (10.4) | 2.87 (1.70) | 19.2 (1.5) | 15.1 (2.1) | 17.5 (1.7) | ||||
30-39 | 73 (14.4) | 3.99 (1.77) | 18.3 (1.3) | 16.5 (1.6) | 20.4 (1.9) | ||||
40-49 | 113 (22.2) | 4.57 (2.06) | 21.3 (1.5) | 19.3 (1.7) | 26.0 (2.2) | ||||
50-59 | 135 (26.6) | 4.22 (1.86) | 21.8 (1.4) | 18.9 (1.6) | 22.3 (1.9) | ||||
≥60 | 134 (26.4) | 5.20 (1.95) | <0.001 | 23.1 (1.3) | <0.001 | 19.3 (1.5) | 0.008 | 27.1 (2.0) | <0.001 |
Residence | |||||||||
Rural area | 305 (60.0) | 4.49 (1.89) | 21.0 (1.4) | 18.5 (1.7) | 24.1 (2.1) | ||||
Urban area | 203 (40.0) | 4.09 (2.01) | 0.12 | 21.4 (1.4) | 0.57 | 18.1 (1.7) | 0.64 | 22.4 (1.9) | 0.24 |
Income (104 KRW/mo) | |||||||||
<100 | 83 (17.1) | 4.34 (2.04) | 22.0 (1.4) | 18.3 (1.5) | 25.5 (2.0) | ||||
100-200 | 112 (23.0) | 4.48 (1.96) | 22.2 (1.4) | 19.3 (1.8) | 25.5 (2.2) | ||||
200-300 | 140 (28.8) | 4.32 (1.82) | 21.3 (1.5) | 17.9 (1.7) | 22.0 (2.1) | ||||
300-400 | 77 (15.8) | 4.42 (1.99) | 20.6 (1.3) | 18.5 (1.6) | 24.4 (1.8) | ||||
400-600 | 55 (11.3) | 3.84 (1.94) | 19.1 (1.3) | 17.0 (1.7) | 19.8 (1.8) | ||||
≥600 | 19 (3.9) | 6.06 (2.10) | 0.23 | 20.4 (1.5) | 0.14 | 20.7 (1.9) | 0.60 | 24.4 (2.1) | 0.19 |
History of smoking | |||||||||
No | 332 (65.9) | 3.74 (1.83) | 20.4 (1.4) | 16.5 (1.6) | 18.6 (1.7) | ||||
Yes | 172 (34.1) | 5.76 (1.96) | <0.001 | 22.8 (1.5) | <0.001 | 22.3 (1.6) | <0.001 | 36.2 (2.1) | <0.001 |
Frequency of alcohol consumption | |||||||||
None | 124 (24.6) | 3.90 (1.95) | 20.9 (1.4) | 17.9 (1.6) | 19.6 (1.7) | ||||
<1/mo | 74 (14.7) | 3.61 (1.90) | 19.7 (1.4) | 16.1 (1.6) | 17.6 (1.7) | ||||
1/mo | 68 (13.5) | 4.41 (1.74) | 20.2 (1.4) | 18.0 (1.7) | 19.9 (1.9) | ||||
2-4 times/mo | 117 (23.2) | 3.97 (1.94) | 19.7 (1.3) | 17.1 (1.6) | 21.6 (1.8) | ||||
2-3 times/wk | 74 (14.7) | 5.29 (1.86) | 23.5 (1.5) | 21.0 (1.8) | 32.8 (2.0) | ||||
4+ times/wk | 48 (9.5) | 6.75 (1.89) | <0.001 | 26.2 (1.5) | <0.001 | 23.0 (1.6) | <0.001 | 51.9 (2.5) | <0.001 |
Fish consumption (g/kg/d) | |||||||||
1st quarter (<0.20) | 117 (23.1) | 3.93 (1.91) | 22.0 (1.4) | 19.7 (1.7) | 27.9 (2.1) | ||||
2nd quarter (0.20-0.72) | 139 (27.4) | 3.90 (1.95) | 20.9 (1.5) | 17.5 (1.7) | 22.4 (2.0) | ||||
3rd quarter (0.73-1.45) | 124 (24.5) | 4.14 (1.95) | 20.8 (1.4) | 17.5 (1.7) | 20.7 (1.9) | ||||
4th quarter (≥1.46) | 127 (25.0) | 5.55 (1.83) | <0.001 | 21.1 (1.3) | 0.61 | 18.9 (1.6) | 0.18 | 23.8 (2.0) | 0.007 |
Past medical history | |||||||||
Hypertension | |||||||||
No | 362 (73.6) | 4.07 (1.91) | 20.5 (1.4) | 17.4 (1.7) | 21.3 (1.9) | ||||
Yes | 130 (26.4) | 5.13 (2.00) | 0.001 | 22.7 (1.4) | 0.003 | 20.7 (1.6) | 0.001 | 29.4 (2.1) | <0.001 |
Diabetes mellitus | |||||||||
No | 433 (88.5) | 4.34 (1.97) | 20.8 (1.4) | 17.8 (1.7) | 22.6 (2.0) | ||||
Yes | 56 (11.5) | 4.27 (1.82) | 0.86 | 22.6 (1.4) | 0.08 | 21.7 (1.7) | 0.007 | 29.0 (2.0) | 0.01 |
Kidney disease | |||||||||
No | 455 (94.6) | 4.36 (1.97) | 21.0 (1.4) | 18.4 (1.7) | 23.5 (2.0) | ||||
Yes | 26 (5.4) | 4.33 (1.80) | 0.96 | 20.5 (1.2) | 0.70 | 15.7 (1.3) | 0.12 | 19.4 (1.7) | 0.18 |
Tuberculosis | |||||||||
No | 453 (94.4) | 4.26 (1.95) | 20.9 (1.4) | 17.9 (1.7) | 23.0 (2.0) | ||||
Yes | 27 (5.6) | 6.15 (1.94) | 0.006 | 23.4 (1.4) | 0.08 | 24.1 (1.7) | 0.003 | 28.6 (2.0) | 0.11 |
Dyslipidemia | |||||||||
No | 448 (92.8) | 4.34 (1.96) | 21.0 (1.4) | 18.2 (1.7) | 23.2 (2.0) | ||||
Yes | 35 (7.2) | 4.35 (1.82) | 0.99 | 21.0 (1.3) | 0.95 | 19.3 (1.7) | 0.53 | 24.3 (1.9) | 0.72 |
Hepatitis B | |||||||||
No | 439 (92.0) | 4.38 (1.93) | 20.8 (1.4) | 18.0 (1.7) | 23.2 (2.0) | ||||
Yes | 38 (8.0) | 4.44 (2.07) | 0.91 | 23.1 (1.4) | 0.06 | 21.6 (1.6) | 0.03 | 22.7 (1.8) | 0.85 |
Values are presented as geometric mean (geometric standard deviation).
Hg, mercury; AST, aspartate aminotransferase; ALT, alanine transaminase; GGT, gamma-glutamyltransferase; KRW, Korean won.
1 p-values were calculated using the t-test or analysis of variance with natural log-transformed values of Hg, AST, ALT, and GGT.
Survey wave (periods) | Blood Hg or liver enzymes | Mean (SD) | gMean (gSD) | Min | 1st Q | Median | 3rd Q | Max | p-value1 |
---|---|---|---|---|---|---|---|---|---|
Baseline (2010-2011) | Hg (μg/L) | 5.44 (4.40) | 4.33 (1.94) | 0.46 | 2.90 | 4.22 | 6.54 | 41.95 | |
AST (IU/L) | 22.8 (12.9) | 21.2 (1.4) | 10.0 | 17.0 | 20.0 | 24.0 | 187.0 | ||
ALT (IU/L) | 21.3 (15.2) | 18.3 (1.7) | 5.0 | 13.0 | 17.0 | 24.0 | 153.0 | ||
GGT (IU/L) | 31.9 (37.8) | 23.4 (2.0) | 7.0 | 14.0 | 20.0 | 36.0 | 473.0 | ||
Follow-up (2014-2015) | Hg (μg/L) | 4.08 (3.44) | 3.18 (2.00) | 0.31 | 2.02 | 3.05 | 5.01 | 26.90 | <0.001 |
AST (IU/L) | 21.8 (16.2) | 18.3 (1.7) | 2.5 | 13.0 | 17.0 | 25.0 | 169.0 | <0.001 | |
ALT (IU/L) | 22.5 (10.8) | 20.9 (1.4) | 9.0 | 16.0 | 20.0 | 25.0 | 93.0 | <0.001 | |
GGT (IU/L) | 32.7 (42.2) | 23.8 (2.0) | 6.0 | 14.0 | 21.0 | 36.0 | 589.0 | 0.38 |
Hg, mercury; SD, standard deviation; gMean, geometric mean; gSD, geometric standard deviation; Min, minimum; 1st Q, 1st quartile; 3rd Q, 3rd quartile; Max, maximum; AST, aspartate aminotransferase; ALT, alanine transaminase; GGT, gamma-glutamyltransferase.
1 p-values were calculated using the paired t-test for differences in the geometric mean between survey waves.
Survey wave |
AST |
ALT |
GGT |
||||
---|---|---|---|---|---|---|---|
% change (95% CI)2 | p for interaction3 | % change (95% CI)2 | p for interaction3 | % change (95% CI)2 | p for interaction3 | ||
All | Baseline | -1.2 (-4.7, 2.5) | 2.2 (-3.3, 7.9) | 8.3 (1.8, 15.2)* | |||
Follow-up | 3.6 (-2.2, 9.8) | 0.03 | -0.6 (-4.2, 3.1) | 0.003 | 10.3 (3.5, 17.6)* | 0.60 | |
Men | Baseline | -2.5 (-7.9, 3.3) | 0.7 (-7.3, 9.3) | 6.1 (-4.8, 18.2) | |||
Follow-up | 0.9 (-7.0, 9.4) | 0.69 | -3.1 (-8.6, 2.8) | 0.16 | 9.4 (-2.0, 22.2) | 0.70 | |
Womene | Baseline | -0.5 (-5.3, 4.6) | 3.0 (-4.4, 11.0) | 9.7 (1.7, 18.2)* | |||
Follow-up | 5.6 (-2.8, 14.7) | 0.12 | 2.1 (-2.9, 7.3) | 0.54 | 12.3 (3.5, 21.8)* | 0.61 |
Hg, mercury; AST, aspartate aminotransferase; ALT, alanine transaminase; GGT, gamma-glutamyltransferase.
1 Generalized linear model adjusted for gender (in all), age, income, fish consumption, smoking, frequency of alcohol consumption, and past medical history of hypertension, diabetes mellitus, tuberculosis, or hepatitis B measured at each period.
2 % change of liver enzyme per doubling of blood Hg levels.
3 Interactions between blood Hg levels and survey wave in association with liver function indices were evaluated by the interaction term in the generalized estimating equation model.
* p<0.05.
AST |
ALT |
GGT |
|||||
---|---|---|---|---|---|---|---|
% change (95% CI)1 | p for interaction2 | % change (95% CI)1 | p for interaction2 | % change (95% CI)1 | p for interaction2 | ||
Men | Crude | 1.8 (-2.4, 6.1) | 0.6 (-3.8, 5.3) | 12.7 (3.2, 23.0)* | |||
Model 1 | 1.6 (-2.7, 6.0) | -0.1 (-4.9, 4.8) | 10.4 (-0.1, 22.1)† | ||||
Model 2 | 1.3 (-3.3, 6.0) | -0.8 (-5.5, 4.1) | 7.5 (-1.8, 17.7) | ||||
Model 3 | -0.1 (-4.7, 4.7) | -1.2 (-5.6, 3.4) | 8.1 (-0.5, 17.4)† | ||||
Alcohol consumption frequency3 | |||||||
≤2-4 times/mo | 3.6 (-2.3, 9.8) | 2.9 (-2.5, 8.6) | 7.6 (-2.0, 18.2) | ||||
≥2-3 times/wk | -1.7 (-9.0, 6.2) | 0.88 | -2.7 (-10.5, 5.7) | 0.31 | 13.5 (-2.0, 31.4)† | 0.39 | |
Women | Crude | 6.9 (2.8, 11.2)* | 0.9 (-2.9, 4.8) | 7.0 (1.1, 13.3)* | |||
Model 1 | 2.1 (-1.9, 6.2) | 1.8 (-2.2, 6.0) | 8.1 (1.4, 15.2)* | ||||
Model 2 | 2.2 (-1.7, 6.2) | 1.5 (-2.4, 5.6) | 9.1 (2.3, 16.3)* | ||||
Model 3 | 3.2 (-1.1, 7.6) | 2.4 (-1.7, 6.6) | 11.0 (4.5, 18.0)* | ||||
Alcohol consumption frequency3 | |||||||
≤2-4 times/mo | 2.5 (-2.2, 7.4) | 2.0 (-2.4, 6.7) | 7.8 (1.2, 14.7)* | ||||
≥2-3 times/wk | 10.6 (4.2, 17.5)* | 0.22 | 7.7 (1.1, 14.7)* | 0.37 | 37.5 (15.2, 64.3)* | 0.008 | |
p for interaction between genders4 | 0.02 | 0.53 | 0.82 |
Model 1 included age, income, and study period in the crude model; Model 2 included fish consumption, smoking, and frequency of alcohol consumption in addition to model 1; Model 3 included past medical history of hypertension, diabetes mellitus, tuberculosis, or hepatitis B in addition to model 2. In each model, age, income, period, fish consumption, smoking, and frequency of alcohol consumption, as well as blood Hg and liver enzyme levels, were considered to be time-varying covariates.
Hg, mercury; CI, confidence interval; AST, aspartate aminotransferase; ALT, alanine transaminase; GGT, gamma-glutamyltransferase.
1 % change of liver enzyme per doubling of blood Hg level.
2 The multiplicative interaction between blood Hg levels and frequency of alcohol consumption in association with liver enzymes was evaluated by the interaction term in the corresponding model.
3 After stratification by frequency of alcohol consumption, the same covariates as model 3 were included.
4 The multiplicative interaction between blood Hg levels and gender in association with liver enzymes was evaluated by the interaction term in the corresponding model (model 3).
† p<0.1,
* p<0.05.
n (%) | Hg (μg/L) | p-value |
AST (IU/L) | p-value |
ALT (IU/L) | p-value |
GGT (IU/L) | p-value |
|
---|---|---|---|---|---|---|---|---|---|
Total | 508 (100.0) | 4.33 (1.94) | 21.2 (1.4) | 18.3 (1.7) | 23.4 (2.0) | ||||
Gender | |||||||||
Men | 211 (41.5) | 5.71 (1.94) | 23.2 (1.4) | 22.6 (1.6) | 36.1 (2.0) | ||||
Women | 297 (58.5) | 3.55 (1.80) | <0.001 | 19.8 (1.4) | <0.001 | 15.7 (1.6) | <0.001 | 17.2 (1.7) | <0.001 |
Age at baseline (y) | |||||||||
≤29 | 53 (10.4) | 2.87 (1.70) | 19.2 (1.5) | 15.1 (2.1) | 17.5 (1.7) | ||||
30-39 | 73 (14.4) | 3.99 (1.77) | 18.3 (1.3) | 16.5 (1.6) | 20.4 (1.9) | ||||
40-49 | 113 (22.2) | 4.57 (2.06) | 21.3 (1.5) | 19.3 (1.7) | 26.0 (2.2) | ||||
50-59 | 135 (26.6) | 4.22 (1.86) | 21.8 (1.4) | 18.9 (1.6) | 22.3 (1.9) | ||||
≥60 | 134 (26.4) | 5.20 (1.95) | <0.001 | 23.1 (1.3) | <0.001 | 19.3 (1.5) | 0.008 | 27.1 (2.0) | <0.001 |
Residence | |||||||||
Rural area | 305 (60.0) | 4.49 (1.89) | 21.0 (1.4) | 18.5 (1.7) | 24.1 (2.1) | ||||
Urban area | 203 (40.0) | 4.09 (2.01) | 0.12 | 21.4 (1.4) | 0.57 | 18.1 (1.7) | 0.64 | 22.4 (1.9) | 0.24 |
Income (104 KRW/mo) | |||||||||
<100 | 83 (17.1) | 4.34 (2.04) | 22.0 (1.4) | 18.3 (1.5) | 25.5 (2.0) | ||||
100-200 | 112 (23.0) | 4.48 (1.96) | 22.2 (1.4) | 19.3 (1.8) | 25.5 (2.2) | ||||
200-300 | 140 (28.8) | 4.32 (1.82) | 21.3 (1.5) | 17.9 (1.7) | 22.0 (2.1) | ||||
300-400 | 77 (15.8) | 4.42 (1.99) | 20.6 (1.3) | 18.5 (1.6) | 24.4 (1.8) | ||||
400-600 | 55 (11.3) | 3.84 (1.94) | 19.1 (1.3) | 17.0 (1.7) | 19.8 (1.8) | ||||
≥600 | 19 (3.9) | 6.06 (2.10) | 0.23 | 20.4 (1.5) | 0.14 | 20.7 (1.9) | 0.60 | 24.4 (2.1) | 0.19 |
History of smoking | |||||||||
No | 332 (65.9) | 3.74 (1.83) | 20.4 (1.4) | 16.5 (1.6) | 18.6 (1.7) | ||||
Yes | 172 (34.1) | 5.76 (1.96) | <0.001 | 22.8 (1.5) | <0.001 | 22.3 (1.6) | <0.001 | 36.2 (2.1) | <0.001 |
Frequency of alcohol consumption | |||||||||
None | 124 (24.6) | 3.90 (1.95) | 20.9 (1.4) | 17.9 (1.6) | 19.6 (1.7) | ||||
<1/mo | 74 (14.7) | 3.61 (1.90) | 19.7 (1.4) | 16.1 (1.6) | 17.6 (1.7) | ||||
1/mo | 68 (13.5) | 4.41 (1.74) | 20.2 (1.4) | 18.0 (1.7) | 19.9 (1.9) | ||||
2-4 times/mo | 117 (23.2) | 3.97 (1.94) | 19.7 (1.3) | 17.1 (1.6) | 21.6 (1.8) | ||||
2-3 times/wk | 74 (14.7) | 5.29 (1.86) | 23.5 (1.5) | 21.0 (1.8) | 32.8 (2.0) | ||||
4+ times/wk | 48 (9.5) | 6.75 (1.89) | <0.001 | 26.2 (1.5) | <0.001 | 23.0 (1.6) | <0.001 | 51.9 (2.5) | <0.001 |
Fish consumption (g/kg/d) | |||||||||
1st quarter (<0.20) | 117 (23.1) | 3.93 (1.91) | 22.0 (1.4) | 19.7 (1.7) | 27.9 (2.1) | ||||
2nd quarter (0.20-0.72) | 139 (27.4) | 3.90 (1.95) | 20.9 (1.5) | 17.5 (1.7) | 22.4 (2.0) | ||||
3rd quarter (0.73-1.45) | 124 (24.5) | 4.14 (1.95) | 20.8 (1.4) | 17.5 (1.7) | 20.7 (1.9) | ||||
4th quarter (≥1.46) | 127 (25.0) | 5.55 (1.83) | <0.001 | 21.1 (1.3) | 0.61 | 18.9 (1.6) | 0.18 | 23.8 (2.0) | 0.007 |
Past medical history | |||||||||
Hypertension | |||||||||
No | 362 (73.6) | 4.07 (1.91) | 20.5 (1.4) | 17.4 (1.7) | 21.3 (1.9) | ||||
Yes | 130 (26.4) | 5.13 (2.00) | 0.001 | 22.7 (1.4) | 0.003 | 20.7 (1.6) | 0.001 | 29.4 (2.1) | <0.001 |
Diabetes mellitus | |||||||||
No | 433 (88.5) | 4.34 (1.97) | 20.8 (1.4) | 17.8 (1.7) | 22.6 (2.0) | ||||
Yes | 56 (11.5) | 4.27 (1.82) | 0.86 | 22.6 (1.4) | 0.08 | 21.7 (1.7) | 0.007 | 29.0 (2.0) | 0.01 |
Kidney disease | |||||||||
No | 455 (94.6) | 4.36 (1.97) | 21.0 (1.4) | 18.4 (1.7) | 23.5 (2.0) | ||||
Yes | 26 (5.4) | 4.33 (1.80) | 0.96 | 20.5 (1.2) | 0.70 | 15.7 (1.3) | 0.12 | 19.4 (1.7) | 0.18 |
Tuberculosis | |||||||||
No | 453 (94.4) | 4.26 (1.95) | 20.9 (1.4) | 17.9 (1.7) | 23.0 (2.0) | ||||
Yes | 27 (5.6) | 6.15 (1.94) | 0.006 | 23.4 (1.4) | 0.08 | 24.1 (1.7) | 0.003 | 28.6 (2.0) | 0.11 |
Dyslipidemia | |||||||||
No | 448 (92.8) | 4.34 (1.96) | 21.0 (1.4) | 18.2 (1.7) | 23.2 (2.0) | ||||
Yes | 35 (7.2) | 4.35 (1.82) | 0.99 | 21.0 (1.3) | 0.95 | 19.3 (1.7) | 0.53 | 24.3 (1.9) | 0.72 |
Hepatitis B | |||||||||
No | 439 (92.0) | 4.38 (1.93) | 20.8 (1.4) | 18.0 (1.7) | 23.2 (2.0) | ||||
Yes | 38 (8.0) | 4.44 (2.07) | 0.91 | 23.1 (1.4) | 0.06 | 21.6 (1.6) | 0.03 | 22.7 (1.8) | 0.85 |
Survey wave (periods) | Blood Hg or liver enzymes | Mean (SD) | gMean (gSD) | Min | 1st Q | Median | 3rd Q | Max | p-value |
---|---|---|---|---|---|---|---|---|---|
Baseline (2010-2011) | Hg (μg/L) | 5.44 (4.40) | 4.33 (1.94) | 0.46 | 2.90 | 4.22 | 6.54 | 41.95 | |
AST (IU/L) | 22.8 (12.9) | 21.2 (1.4) | 10.0 | 17.0 | 20.0 | 24.0 | 187.0 | ||
ALT (IU/L) | 21.3 (15.2) | 18.3 (1.7) | 5.0 | 13.0 | 17.0 | 24.0 | 153.0 | ||
GGT (IU/L) | 31.9 (37.8) | 23.4 (2.0) | 7.0 | 14.0 | 20.0 | 36.0 | 473.0 | ||
Follow-up (2014-2015) | Hg (μg/L) | 4.08 (3.44) | 3.18 (2.00) | 0.31 | 2.02 | 3.05 | 5.01 | 26.90 | <0.001 |
AST (IU/L) | 21.8 (16.2) | 18.3 (1.7) | 2.5 | 13.0 | 17.0 | 25.0 | 169.0 | <0.001 | |
ALT (IU/L) | 22.5 (10.8) | 20.9 (1.4) | 9.0 | 16.0 | 20.0 | 25.0 | 93.0 | <0.001 | |
GGT (IU/L) | 32.7 (42.2) | 23.8 (2.0) | 6.0 | 14.0 | 21.0 | 36.0 | 589.0 | 0.38 |
Survey wave | AST |
ALT |
GGT |
||||
---|---|---|---|---|---|---|---|
% change (95% CI) |
p for interaction |
% change (95% CI) |
p for interaction |
% change (95% CI) |
p for interaction |
||
All | Baseline | -1.2 (-4.7, 2.5) | 2.2 (-3.3, 7.9) | 8.3 (1.8, 15.2) |
|||
Follow-up | 3.6 (-2.2, 9.8) | 0.03 | -0.6 (-4.2, 3.1) | 0.003 | 10.3 (3.5, 17.6) |
0.60 | |
Men | Baseline | -2.5 (-7.9, 3.3) | 0.7 (-7.3, 9.3) | 6.1 (-4.8, 18.2) | |||
Follow-up | 0.9 (-7.0, 9.4) | 0.69 | -3.1 (-8.6, 2.8) | 0.16 | 9.4 (-2.0, 22.2) | 0.70 | |
Womene | Baseline | -0.5 (-5.3, 4.6) | 3.0 (-4.4, 11.0) | 9.7 (1.7, 18.2) |
|||
Follow-up | 5.6 (-2.8, 14.7) | 0.12 | 2.1 (-2.9, 7.3) | 0.54 | 12.3 (3.5, 21.8) |
0.61 |
AST |
ALT |
GGT |
|||||
---|---|---|---|---|---|---|---|
% change (95% CI) |
p for interaction |
% change (95% CI) |
p for interaction |
% change (95% CI) |
p for interaction |
||
Men | Crude | 1.8 (-2.4, 6.1) | 0.6 (-3.8, 5.3) | 12.7 (3.2, 23.0) |
|||
Model 1 | 1.6 (-2.7, 6.0) | -0.1 (-4.9, 4.8) | 10.4 (-0.1, 22.1) |
||||
Model 2 | 1.3 (-3.3, 6.0) | -0.8 (-5.5, 4.1) | 7.5 (-1.8, 17.7) | ||||
Model 3 | -0.1 (-4.7, 4.7) | -1.2 (-5.6, 3.4) | 8.1 (-0.5, 17.4) |
||||
Alcohol consumption frequency |
|||||||
≤2-4 times/mo | 3.6 (-2.3, 9.8) | 2.9 (-2.5, 8.6) | 7.6 (-2.0, 18.2) | ||||
≥2-3 times/wk | -1.7 (-9.0, 6.2) | 0.88 | -2.7 (-10.5, 5.7) | 0.31 | 13.5 (-2.0, 31.4) |
0.39 | |
Women | Crude | 6.9 (2.8, 11.2) |
0.9 (-2.9, 4.8) | 7.0 (1.1, 13.3) |
|||
Model 1 | 2.1 (-1.9, 6.2) | 1.8 (-2.2, 6.0) | 8.1 (1.4, 15.2) |
||||
Model 2 | 2.2 (-1.7, 6.2) | 1.5 (-2.4, 5.6) | 9.1 (2.3, 16.3) |
||||
Model 3 | 3.2 (-1.1, 7.6) | 2.4 (-1.7, 6.6) | 11.0 (4.5, 18.0) |
||||
Alcohol consumption frequency |
|||||||
≤2-4 times/mo | 2.5 (-2.2, 7.4) | 2.0 (-2.4, 6.7) | 7.8 (1.2, 14.7) |
||||
≥2-3 times/wk | 10.6 (4.2, 17.5) |
0.22 | 7.7 (1.1, 14.7) |
0.37 | 37.5 (15.2, 64.3) |
0.008 | |
p for interaction between genders |
0.02 | 0.53 | 0.82 |
Values are presented as geometric mean (geometric standard deviation). Hg, mercury; AST, aspartate aminotransferase; ALT, alanine transaminase; GGT, gamma-glutamyltransferase; KRW, Korean won.
Hg, mercury; SD, standard deviation; gMean, geometric mean; gSD, geometric standard deviation; Min, minimum; 1st Q, 1st quartile; 3rd Q, 3rd quartile; Max, maximum; AST, aspartate aminotransferase; ALT, alanine transaminase; GGT, gamma-glutamyltransferase.
Hg, mercury; AST, aspartate aminotransferase; ALT, alanine transaminase; GGT, gamma-glutamyltransferase. Generalized linear model adjusted for gender (in all), age, income, fish consumption, smoking, frequency of alcohol consumption, and past medical history of hypertension, diabetes mellitus, tuberculosis, or hepatitis B measured at each period. % change of liver enzyme per doubling of blood Hg levels. Interactions between blood Hg levels and survey wave in association with liver function indices were evaluated by the interaction term in the generalized estimating equation model.
Model 1 included age, income, and study period in the crude model; Model 2 included fish consumption, smoking, and frequency of alcohol consumption in addition to model 1; Model 3 included past medical history of hypertension, diabetes mellitus, tuberculosis, or hepatitis B in addition to model 2. In each model, age, income, period, fish consumption, smoking, and frequency of alcohol consumption, as well as blood Hg and liver enzyme levels, were considered to be time-varying covariates. Hg, mercury; CI, confidence interval; AST, aspartate aminotransferase; ALT, alanine transaminase; GGT, gamma-glutamyltransferase. % change of liver enzyme per doubling of blood Hg level. The multiplicative interaction between blood Hg levels and frequency of alcohol consumption in association with liver enzymes was evaluated by the interaction term in the corresponding model. After stratification by frequency of alcohol consumption, the same covariates as model 3 were included. The multiplicative interaction between blood Hg levels and gender in association with liver enzymes was evaluated by the interaction term in the corresponding model (model 3).